학술논문
Patient-reported improvements following omalizumab for nasal polyps during the POLYP 1 and 2 open-label extension.
Document Type
Article
Author
Source
Rhinology Supplement; 2021 Supplement, Vol. 61, p550-550, 1p
Subject
Language
ISSN
10130047